Table 2. The effects of Met and IOs on the body weight (g) in diabetic mice were analyzed.
Week 0 (g) | Week 1 (g) | Week 2 (g) | Week 3 (g) | Week 4 (g) | |
---|---|---|---|---|---|
CTRL | 20.0±0.3 | 22.0±0.3 | 22.7±0.3 | 24.6±0.2 | 24.9±0.3 |
Model | 19.8±0.2 | 16.0±0.4### | 14.9±0.4### | 15.2±0.3### | 15.1±0.3### |
Met | 20.0±0.3 | 15.9±0.2 | 16.2±0.4* | 17.3±0.5* | 17.1±0.5* |
IO1 | 19.8±0.3 | 16.8±0.3 | 16.5±0.4* | 16.7±0.4* | 16.8±0.3* |
IO2 | 19.6±0.1 | 15.0±0.6 | 15.0±0.5 | 15.5±0.6 | 15.1±0.6^ |
IO3 | 19.7±0.2 | 15.3±0.5 | 15.3±0.5 | 15.7±0.8 | 16.6±0.5* |
IO4 | 19.5±0.1 | 15.9±0.4 | 16.6±0.6* | 17.1±0.5* | 16.9±0.5* |
IO5 | 19.6±0.2 | 16.6±±0.4 | 17.6±0.2** | 17.9±0.3** | 17.6±0.30** |
Data are expressed as mean ± S.E.M. (n = 10) and analyzed by using a one-way ANOVA.
### P < 0.001 versus normal controls
* P < 0.05 and
** P < 0.01 versus model group
^ P < 0.05 versus Met-treated group.